Hoffmann La Roche patent expiration

1. Boniva patent expiration

BONIVA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6143326 HOFFMANN LA ROCHE Oral pharmaceutical preparation containing ibandronat
Apr, 2017

(7 years ago)

US6294196 HOFFMANN LA ROCHE Pharmaceutical composition containing diphosphonic acid or salt thereof
Oct, 2019

(4 years ago)

US7192938 HOFFMANN LA ROCHE Method of treatment using bisphosphonic acid
May, 2023

(1 year, 2 months ago)

US7410957 HOFFMANN LA ROCHE Method of treatment using bisphosphonic acid
May, 2023

(1 year, 2 months ago)

US7718634 HOFFMANN LA ROCHE Method of treatment using bisphosphonic acid
May, 2023

(1 year, 2 months ago)




Drugs and Companies using IBANDRONATE SODIUM ingredient

Market Authorisation Date: 16 May, 2003

Treatment: Treatment and prevention of osteoporosis; Treatment and prevention of osteoporosis in postmenopausal women by once-monthly oral administration of ibandronate sodium monohydrate equivalent to 150mg of ...

Dosage: TABLET

How can I launch a generic of BONIVA before it's drug patent expiration?
More Information on Dosage

BONIVA family patents

Family Patents

2. Fortovase patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6008228 HOFFMANN LA ROCHE Pharmaceutical compositions containing proteinase inhibitors
Jun, 2015

(9 years ago)

US6008228

(Pediatric)

HOFFMANN LA ROCHE Pharmaceutical compositions containing proteinase inhibitors
Dec, 2015

(8 years ago)

US6352717 HOFFMANN LA ROCHE Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses
Nov, 2019

(4 years ago)

US6352717

(Pediatric)

HOFFMANN LA ROCHE Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses
May, 2020

(4 years ago)




Drugs and Companies using SAQUINAVIR ingredient

Market Authorisation Date: 07 November, 1997

Treatment: NA

Dosage: CAPSULE

More Information on Dosage

FORTOVASE family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Zelboraf patent expiration

ZELBORAF's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8143271 HOFFMANN LA ROCHE NA
Jun, 2026

(1 year, 11 months from now)

US7504509 HOFFMANN LA ROCHE Compounds and methods for development of Ret modulators
Oct, 2026

(2 years from now)

US7863288 HOFFMANN LA ROCHE NA
Jun, 2029

(4 years from now)

US8741920 HOFFMANN LA ROCHE Process for the manufacture of pharmaceutically active compounds
Jul, 2030

(6 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8470818 HOFFMANN LA ROCHE NA
Aug, 2026

(2 years from now)

US9447089 HOFFMANN LA ROCHE Compositions and uses thereof
Jun, 2032

(7 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Aug 17, 2016
Orphan Drug Exclusivity(ODE-13) Aug 17, 2018
Orphan Drug Exclusivity(ODE) Aug 17, 2018
M(M-184) Aug 31, 2019
New Indication(I-757) Nov 06, 2020
Orphan Drug Exclusivity(ODE-158) Nov 06, 2024

Drugs and Companies using VEMURAFENIB ingredient

NCE-1 date: 18 August, 2015

Market Authorisation Date: 17 August, 2011

Treatment: Treatment of patients with unresectable or metastatic melanoma with brafv600e mutation as detected by an fda approved test

Dosage: TABLET

More Information on Dosage

ZELBORAF family patents

Family Patents